GlassScriptPhysician profile
David P Johnston
NPI 1548228133
$10,984.04
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,878 · 2020: $4,982 · 2021: $245 · 2022: $521 · 2023: $111 · 2024: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $9,600.00 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $440.22 | 2021-2024 | Venclose Maven Catheter |
| Venclose INC. | $130.19 | 2020 | |
| Medtronic, INC. | $115.12 | 2023-2024 | Reliatack, Parietene Ds |
| Merck Sharp & Dohme LLC | $78.90 | 2021-2024 | Lynparza, Keytruda |
| Portola Pharmaceuticals, LLC | $43.47 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $43.30 | 2022-2023 | Exparel |
| Takeda Pharmaceuticals U.S.A., INC. | $38.87 | 2022-2024 | Gattex |
| Tela Bio, INC. | $38.16 | 2022 | |
| Integra Lifesciences Corporation | $33.54 | 2021 | |
| Merit Medical Systems INC | $33.46 | 2021 | |
| Smith+Nephew, INC. | $32.80 | 2024 | Renasys Touch |
| Heron Therapeutics, INC. | $32.06 | 2021-2022 | |
| Hologic INC | $27.88 | 2021 | |
| Solventum Corporation | $26.71 | 2024 | V.A.C. Veraflo, Activ.A.C., Prevena |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $25.74 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $25.10 | 2024 | Gore Synecor Biomaterial |
| Davol INC. | $23.31 | 2019 | |
| Abbvie INC. | $22.15 | 2022 | |
| Springworks Therapeutics, INC. | $20.57 | 2024 | Ogsiveo |
| Dilon Technologies, INC. | $18.60 | 2021 | |
| Baudax Bio INC. | $18.50 | 2021 | |
| Alexion Pharmaceuticals, INC. | $18.44 | 2022 | |
| Endo Pharmaceuticals INC. | $15.87 | 2021 | |
| Organogenesis INC. | $15.68 | 2022 | |
| Nestle Healthcare Nutrition INC. | $15.40 | 2022 | |
| Medela LLC | $13.38 | 2020 | |
| Reprise Biomedical, INC. | $13.36 | 2020 | |
| Acell, INC. | $12.05 | 2020 | |
| Focal Therapeutics, INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.